MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2012-03-21 for EXOGEN 4000 71034100 manufactured by Smith & Nephew Orthopaedics, Inc..
[2629736]
It was reported that a patient developed skin sores while using the exogen unit.
Patient Sequence No: 1, Text Type: D, B5
[9761485]
.
Patient Sequence No: 1, Text Type: N, H10
Report Number | 1020279-2012-00178 |
MDR Report Key | 2498940 |
Report Source | 04 |
Date Received | 2012-03-21 |
Date of Report | 2012-03-20 |
Date of Event | 2012-03-20 |
Date Mfgr Received | 2012-03-20 |
Device Manufacturer Date | 2012-01-01 |
Date Added to Maude | 2012-03-21 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Reporter Occupation | PATIENT |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 0 |
Event Location | 0 |
Manufacturer Contact | MR PHILLIP EMMERT |
Manufacturer Street | 1450 E. BROOKS RD |
Manufacturer City | MEMPHIS TN 38116 |
Manufacturer Country | US |
Manufacturer Postal | 38116 |
Manufacturer Phone | 9013995296 |
Manufacturer G1 | SMITH AND NEPHEW, INC. |
Manufacturer Street | 1450E. BROOKS RD |
Manufacturer City | MEMPHIS TN 38116 |
Manufacturer Country | US |
Manufacturer Postal Code | 38116 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | EXOGEN 4000 |
Generic Name | BONE GROWTH STIMULATOR |
Product Code | LPQ |
Date Received | 2012-03-21 |
Catalog Number | 71034100 |
Lot Number | 0112003927E |
Operator | LAY USER/PATIENT |
Device Availability | Y |
Device Age | DA |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | SMITH & NEPHEW ORTHOPAEDICS, INC. |
Manufacturer Address | 1450 BROOKS ROAD MEMPHIS TN 38116 US 38116 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Hospitalization; 2. Required No Informationntervention | 2012-03-21 |